CClinicalTrials.gg
RecruitingNCT07016425Updated Jul 16, 2025

Temporal Interference for Essential Tremor

An interventional study of Temporal Interference in Essential Tremor, sponsored by Liankun_Ren. Recruiting at 1 site in China. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-07-16.

Sponsored by Liankun_Ren · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
30 Years to 70 Years
Sex
All
01

Study summary

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in essential tremor patients aged 30-70.

Read the detailed description

Temporal Interference (TI) technology is a novel non-invasive method for deep brain stimulation (DBS). By generating an overlapping electric field from safe currents, TI creates focused stimulation in targeted deep brain areas. This approach allows for the exploration of deep brain nuclei functions and has the potential to serve as a non-invasive alternative to traditional invasive DBS for clinical treatments.

This study aims to investigate the treatment efficacy of TI deep brain stimulation by including essential tremor patients aged 30-70. Before and after TI stimulation, clinical data will be recorded. Clinical and imaging data will be analyzed and processed to advance the treatment of essential tremor.

02

Conditions studied

  • Essential Tremor

Browse trials for

Keywords

  • Temporal Interference
  • Essential Tremor
03

In context

Essential Tremor

261 studies on the registry are indexed under Essential Tremor; 74 are open to participants now.

This study's planned enrollment of 10 is below the median of 24 across 185 interventional studies indexed under Essential Tremor.

Browse Essential Tremor studies →

Lead sponsor

Liankun_Ren is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 30-70 years old, regardless of gender. Action tremor and postural tremor in both upper limbs, or action tremor and postural tremor in one limb;
  • No history of mental diseases;
  • Informed consent signed.

Exclusion criteria

Exclusion Criteria:

  • Presence of other neurological diseases affecting the study (such as epilepsy);
  • Patients with moderate to severe cognitive impairment (Montreal Cognitive Assessment ≤ 18 points);
  • Orthopedic diseases that may affect motor symptoms;
  • Patients taking antipsychotic or antidepressant medications;
  • Presence of metal implants in the body (such as brain pacemakers or cardiac pacemakers);
  • History of electroconvulsive therapy;
  • Presence of cardiovascular risk factors, etc.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Temporal Interference

    The investigators perform temporal interference (TI) stimulation to patients with essential tremor. They observe clinical manifestations before and after stimulation to investigate the efficiency of TI.

    Other: Temporal Interference

Interventions

  • OtherTemporal Interference

    Researchers apply temporal interference (TI) stimulation to the deep brain nuclei of essential tremor patients.

06

What researchers measure

Primary outcomes

  1. Tremor Level Evaluation

    Percentage change in per month after stimulation from baseline in The Essential Tremor Rating Assessment Scale(TETRAS) score. The TETRAS score ranges from 0 to 112, including an activities of daily living (ADL) section(0-48 scores) and a performance section(0-64 scores), with higher scores representing more severe tremor and lower scores indicating lower tremor level

    Time frame: Up to 3 months after TI stimulation

07

Study locations

1 of 1 sites recruiting
  • Xuanwu Hospital, Capital Medical University
    Beijing, Beijing Municipality 100053, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07016425
Lead sponsor
Liankun_Ren
Responsible party
Liankun_Ren (Professor, Xuanwu Hospital, Beijing) — Sponsor-investigator
First posted
Jun 11, 2025
Start date
Jun 9, 2025
Primary completion
May 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Jul 16, 2025

Study contacts

Liankun Ren, MD
Contact
renlk2022@outlook.com
+86 13681576621
Liankun Ren, MD
principal investigator · Xuanwu Hospital, Beijing

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion